
Providence Therapeutics
@providencethera
A clinical-stage #mRNA platform company developing #vaccines for #cancers and #InfectiousDiseases that pose public health risks
ID: 1641510108487114766
https://providencetherapeutics.com/ 30-03-2023 18:38:35
16 Tweet
80 Followers
219 Following




Happy National #Immunization Awareness Week! We're proud to support this campaign led by Immunize Canada & Cdn Public Health Assoc. highlighting the importance of routine immunizations to protect the Canadian population against vaccine-preventable diseases. #NIAW2023 #VaccinesWork #GetImmunized


Our CFO, Judyanna Yu, CPA, CA, and President & CTO, Robert Georgantas III, Ph.D., are attending Biotechnology Innovation Organization's BIO International Convention in Boston from June 5-8. Please reach out if you’d like to meet us there: bit.ly/41ZaCD0 #BIO2023



Our President & Chief Technology Officer, Robert Georgantas III, Ph.D., is participating in BioProcess Online upcoming panel to discuss the therapeutic #vaccine revolution and overcoming development and manufacturing challenges. Register for the panel here: bit.ly/3IqoQFj


A new paper in Scientific Reports, an open-access part of the Nature Portfolio, details the results of Providence's Phase 1 study of its mRNA-based COVID-19 vaccine candidate, the first clinical study to demonstrate encouraging data on Providence's mRNA platform: nature.com/articles/s4159…


Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., look forward to meeting fellow industry leaders at the Biotechnology Innovation Organization Convention. Reach out if you would like to meet us there: bit.ly/41ZaCD0 #BIO2023


We are thrilled to announce our partnership with the University Health Network to develop mRNA-based vaccines and therapeutics for those living with difficult-to-treat #cancers and #InfectiousDiseases. Learn more about our collaboration with the University Health Network here: bit.ly/43k8Mxk


Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., are enjoying connecting with industry leaders at the Biotechnology Innovation Organization Convention. Reach out if you would like to meet: bit.ly/41ZaCD0 #BIO2023


Our Chief Science Officer, Natalia Martin Orozco, Ph.D., will present at the Mexican Society of Immunology's 25th National Congress in Santiago de QuerĂ©taro, Mexico on Wednesday, June 7. Learn more here: bit.ly/426FKQb Sociedad Mexicana de InmunologĂa (SMI)


We're proud to be a gold sponsor of the Western Canada RNA Conference, RiboWest 2023, which brings together #RNA scientists from across #Canada and the northwestern United States. Our team will present on June 26 at 2:15 p.m. PT at University of Northern British Columbia (UNBC). Learn more here: fal.cn/3zlZK



Our President & CTO, Robert Georgantas III, Ph.D., was featured in a Drug Discovery News article highlighting the advantages of mRNA-based vaccines and our pipeline of vaccines in development for aggressive #cancers and #InfectiousDiseases. Read more here: fal.cn/3AkJ2